Prognostic Evaluation of Vitrectomy Assisted by Lucentis in Diabetic Retinopathy and Neovascular Glaucoma
Source : https://www.hindawi.com/journals/ecam/2022/4127293/
For verifying the prognosis of Lucentis-assisted vitrectomy (PPV) in diabetic retinopathy (DR) and neovascular glaucoma (NVG), a retrospective analysis of DR and NVG patients who were admitted to our hospital...
Conclusion/Relevance: Therefore, the study reached the following conclusions about vitrectomy assisted by Lucentis: (1) it effectively increases the success rate of treatment, decreases postoperative complications as well as surgical risks, and improves patients’ vision; (2) it promotes the recovery of IOP, reduces macular edema and VEGF...
Relationship of Retinal Vessel Caliber with Age-Related Macular Degeneration
Source : https://www.hindawi.com/journals/joph/2022/8210599/
Purpose . Evaluate the relationship between retinal vascular caliber and age-related macular degeneration (AMD) severity or progression. Methods . A retrospective secondary analysis of 1172 fundus photographs and clinical data...
Conclusion: A lower arteriole-to-venule ratio may be associated with AMD severity, with narrower arterioles seen in the eyes with geographic atrophy, suggesting a role of the retinal vasculature in AMD pathophysiology. This trial is registered with ClinicalTrials.gov Identifier: NCT00000145.
The Effect of Sample Medication Use on Subsequent Anti-VEGF Agent Selection for Neovascular Age-Related Macular Degeneration
Source : https://www.tandfonline.com/doi/abs/10.1080/08820538.2022.2107398?journalCode=isio20
ABSTRACT Medication samples of anti-VEGF agents can represent a good option for retina specialists to provide timely treatment for newly converted neovascular age-related macular degeneration (nvAMD) while prior-authorizations (PA) are...
Conclusions: Sample medications in nvAMD may be initiated for many reasons, including awaiting PA approval. Our study found that eyes receiving a sample anti-VEGF agent (ranibizumab or aflibercept) for their initial injection were less likely to receive bevacizumab at future visits relative to eyes that did not receive an anti-VEGF sample,...
Time course of changes in vision-related quality of life following intravitreal ranibizumab treatment for branch retinal vein occlusion - Scientific Reports
Source : https://www.nature.com/articles/s41598-022-17587-0
To evaluate the vision-related quality of life (VR-QOL) treated by intravitreal ranibizumab (IVR) in patients with branch retinal vein occlusion (BRVO) and to assess subscale items of the VR-QOL. This...
Relevance: To evaluate the vision-related quality of life (VR-QOL) treated by intravitreal ranibizumab (IVR) in patients with branch retinal vein occlusion (BRVO) and to assess subscale items of the VR-QOL.
Reduction of Laser-Induced Choroidal Neovascularization in Mice With Erythropoietin RNA Interference
Source : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351596/
Wenjuan Lv, 1 , * Wen Chen, 1 , 2 , * Shaofen Huang, 1 Yanxuan Xu, 1 Jia-Jian Liang, 1 Yuqian Zheng, 1 Shaowan Chen, 1 Shao-Lang Chen, 1...
Conclusions: This study revealed the promotion of human endothelial cell tube formation in vitro and choroid sprouting ex vivo by EPO, and the reduction of laser-induced CNV in vivo by Epo RNA interference.